Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL)

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Oct 20, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to treat cancer using a special machine called the Integrated Magnetic Resonance Linear Accelerator (MRL). The goal is to see if this method, which combines advanced imaging with targeted radiation therapy, can help patients get better results from their treatment. Participants in the study will be adults aged 18 and older who have been diagnosed with cancer and are scheduled to receive this type of radiation therapy. They will also need to be able to understand and agree to the study terms.

If you join this trial, you can expect to have some extra MRI scans during your treatment planning to help doctors see your cancer more clearly. You'll also be asked to fill out some questionnaires about your quality of life during the study. This information will help researchers understand how well this new treatment works and how it affects patients' daily lives. The trial is currently recruiting participants, so if you're interested, you may have the opportunity to take part in this innovative approach to cancer care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients 18 years or older with a diagnosis of cancer, regardless of clinical site or stage
• • Planned to receive a course of MR-guided adaptive RT using the MRL
• • Ability to provide informed consent
• Exclusion Criteria:
• • Patients under 18 years old